An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder Treated With Quetiapine XR and/or Quetiapine IR
Phase of Trial: Phase IV
Latest Information Update: 28 Jan 2013
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar disorders
- Focus Therapeutic Use
- Acronyms REED
- Sponsors AstraZeneca
- 08 May 2012 Actual end date 1 Apr 2012 added as reported by ClinicalTrials.gov.
- 08 May 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 26 Oct 2011 New trial record